Last reviewed · How we verify
NCT07296549
Expert Consensus on the Clinical Management of Melasma: A Delphi Method Study
trial in Melasma in 15 participants. Enrolling by invitation.
1 September 2026
Quick facts
| Lead sponsor | Venus Research Center |
|---|---|
| Status | ENROLLING BY INVITATION |
| Study type | OBSERVATIONAL |
| Enrollment | 15 |
| Start date | 1 June 2026 |
| Primary completion | 1 September 2026 |
| Estimated completion | 30 December 2026 |
| Sites | 1 location across Egypt |
Conditions studied
- Melasma — all drugs for Melasma →
- Melasma (Facial Melasma) — all drugs for Melasma (Facial Melasma) →
Sponsor
Venus Research Center
Who can join
25 and older, any sex, with Melasma or Melasma (Facial Melasma). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to gather expert opinions on the best ways to treat and manage melasma, a common skin condition characterized by dark patches on the face. Using a method called the Delphi Method, a group of dermatologists and other specialists will participate in several rounds of surveys to share their insights and reach a consensus on the most effective treatments and management strategies. The goal is to create a set of evidence-based guidelines that can help doctors provide more consistent, effective care for patients with melasma. The study will ensure that all experts' opinions are anonymous, and the results will be shared to improve treatment practices worldwide.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07296549
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Melasma
Currently open trials in the same condition.
- NCT06845540 — Oral Metformin for Treating Melasma in Latin American Women · Phase 1, PHASE2 · recruiting
- NCT06644157 — Treatment and Prevention of Melasma Relapses by Using 1064nm 650 Microsecond Laser · NA · active not recruiting
- NCT07034560 — Effectiveness of Oral Melatonin vs Oral Tranexamic Acid in the Treatment and Recurrence of Melasma · Phase 4 · active not recruiting
- NCT06516419 — Development of Products Based on Secretom From Stem Cell Conditioned Medium for Melasma Therapy · NA · recruiting
- NCT05942248 — The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis · NA · recruiting
Other Venus Research Center trials
Trials by the same sponsor.
- NCT07334353 — Consensus Guidelines for Pre- and Post-Procedure Skincare in Aesthetic Treatments · enrolling by invitation
- NCT07296588 — Expert Consensus on Photoprotection Practices: A Delphi Study · enrolling by invitation
- NCT07296523 — Expert Consensus on the Use of Isotretinoin in Acne Vulgaris: A Delphi Study · enrolling by invitation
- NCT07296562 — Expert Consensus on the Use of Nutraceuticals in Pregnancy: A Delphi Study · enrolling by invitation
- NCT07296536 — Expert Consensus on the Use of Isotretinoin in Rejuvenation: A Delphi Study · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07296549 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Venus Research Center
- Last refreshed: 29 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07296549.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing